unknown
Stage
2
Investors
About
Black Diamond Therapeutics develops precision oncology therapies by leveraging its proprietary platform to identify and target oncogenic mutations in genetically defined patient populations.
Explore Black Diamond Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.